| 1 |
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
Srikant Rangaraju, Eric B. Dammer, Syed Ali Raza et al. · Molecular Neurodegeneration
Open access |
21 May 2018 |
473 |
| 2 |
Peptide therapeutics from venom: Current status and potential
Michael W. Pennington, Andrzej A. Czerwiński, Raymond S. Norton · Bioorganic & Medicinal Chemistry
Open access |
23 Sep 2017 |
285 |
| 3 |
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
Victor Chi, Michael W. Pennington, Raymond S. Norton et al. · Toxicon
Open access |
15 Aug 2011 |
216 |
| 4 |
Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor
M.L. Flinspach, Qiaojie Xu, Andrew D. Piekarz et al. · Scientific Reports
Open access |
3 Jan 2017 |
124 |
| 5 |
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
Eric J. Tarcha et al. · Journal of Pharmacology and Experimental Therapeutics
Open access |
26 May 2012 |
118 |
| 6 |
Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double‐blind trial
Robert B. Chinnapongse, Kristen L. Gullo, Paul R. Nemeth et al. · Movement Disorders
|
Sep 2011 |
106 |
| 7 |
Analogs of the Sea Anemone Potassium Channel Blocker ShK for the Treatment of Autoimmune Diseases
Christine Beeton, Michael W. Pennington, Raymond S. Norton · Inflammation & Allergy - Drug Targets
Open access |
Oct 2011 |
100 |
| 8 |
Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
Sandeep Chhabra et al. · The FASEB Journal
Open access |
2 Jun 2014 |
92 |
| 9 |
A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation
Srikant Rangaraju, Syed Ali Raza, Andrea Pennati et al. · Journal of Neuroinflammation
Open access |
26 Jun 2017 |
88 |
| 10 |
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
Harunur Rashid, Redwan Huq, Mark R. Tanner et al. · Scientific Reports
Open access |
28 Mar 2014 |
82 |
| 11 |
Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
Stuart Isaacson, Mark Lew, William G. Ondo et al. · Movement Disorders Clinical Practice
Open access |
25 May 2016 |
79 |
| 12 |
Blockade of Kv1.3 channels ameliorates radiation-induced brain injury
Ying Peng, Kui Lu, Zichen Li et al. · Neuro-Oncology
Open access |
4 Dec 2013 |
78 |
| 13 |
Intranasal Drug Delivery of Olanzapine-Loaded Chitosan Nanoparticles
Sarah Baltzley, Mohammad Atiquzzaman, Ahmad H. Malkawi et al. · AAPS PharmSciTech
Open access |
20 Aug 2014 |
78 |
| 14 |
FITC-Conjugated Cyclic RGD Peptides as Fluorescent Probes for Staining Integrin αvβ3/αvβ5 in Tumor Tissues
Yumin Zheng, Shundong Ji, Andrzej A. Czerwiński et al. · Bioconjugate Chemistry
Open access |
13 Oct 2014 |
77 |
| 15 |
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog
Mark R. Tanner, Rajeev B. Tajhya, Redwan Huq et al. · Clinical Immunology
Open access |
4 Apr 2017 |
75 |
| 16 |
A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal
Charles W. Gorodetzky, SHARON L. WALSH, Peter Martin et al. · Drug and Alcohol Dependence
Open access |
10 May 2017 |
72 |
| 17 |
Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
Michael W. Pennington, Shih Yu Chang, Satendra S. Chauhan et al. · Marine Drugs
Open access |
16 Jan 2015 |
71 |
| 18 |
Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults
Stuart Isaacson, William G. Ondo, Carlayne E. Jackson et al. · JAMA Neurology
Open access |
13 Jan 2020 |
70 |
| 19 |
Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
Shyny Koshy, Redwan Huq, Mark R. Tanner et al. · Journal of Biological Chemistry
Open access |
19 Mar 2014 |
70 |
| 20 |
A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
M. Harunur Rashid, Germano Heinzelmann, Redwan Huq et al. · PLoS ONE
Open access |
7 Nov 2013 |
68 |
| 21 |
The effect of obestatin on porcine ovarian granulosa cells
Monika Mészárosová, Alexander V. Sirotkin, R. Grossmann et al. · Animal Reproduction Science
|
28 Aug 2007 |
60 |
| 22 |
Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes
Shyny Koshy, Danli Wu, Xueyou Hu et al. · PLoS ONE
Open access |
11 Oct 2013 |
58 |
| 23 |
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine
Sunita Gulati, Michael W. Pennington, Andrzej A. Czerwiński et al. · mBio
Open access |
5 Nov 2019 |
57 |
| 24 |
Total Synthesis of Human Hepcidin through Regioselective Disulfide‐Bond Formation by using the Safety‐Catch Cysteine Protecting Group 4,4′‐Dimethylsulfinylbenzhydryl
Zoltan Dekan, Mehdi Mobli, Michael W. Pennington et al. · Angewandte Chemie International Edition
|
7 Feb 2014 |
54 |
| 25 |
Effects of chronic food restriction and treatments with leptin or ghrelin on different reproductive parameters of male rats
Alexander V. Sirotkin, Maria Chrenkova, Soňa Nitrayová et al. · Peptides
|
25 Mar 2008 |
44 |
| 26 |
99mTc-Galacto-RGD2: A Novel 99mTc-Labeled Cyclic RGD Peptide Dimer Useful for Tumor Imaging
Shundong Ji, Andrzej A. Czerwiński, Yang Zhou et al. · Molecular Pharmaceutics
Open access |
22 Jul 2013 |
43 |
| 27 |
A C‐terminally amidated analogue of ShK is a potent and selective blocker of the voltage‐gated potassium channel Kv1.3
Michael W. Pennington, M. Harunur Rashid, Rajeev B. Tajhya et al. · FEBS Letters
Open access |
9 Oct 2012 |
41 |
| 28 |
Facile preparation of disulfide‐bridged peptides using the polymer‐supported oxidant CLEAR‐OXTM*
Krzysztof Darłak, DeAnna Wiegandt Long, Andrzej A. Czerwiński et al. · Journal of Peptide Research
|
Mar 2004 |
41 |
| 29 |
Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection
Robert A. Hauser, Stuart Isaacson, Thomas Clinch · Parkinsonism & Related Disorders
|
27 Aug 2014 |
38 |
| 30 |
Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification
Margaret Vernon, Stefan Reinders, Sally Mannix et al. · Addictive Behaviors
|
3 Apr 2016 |
35 |
| 31 |
Involvement of the transcription factor STAT1 in the regulation of porcine ovarian granulosa cell functions treated and not treated with ghrelin
Andrej Benčo, Alexander V. Sirotkin, Dušan Vašíček et al. · Reproduction
Open access |
15 Jun 2009 |
35 |
| 32 |
Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases
Liang Jin, Qi Tony Zhou, Hak‐Kim Chan et al. · Journal of Pharmaceutical Sciences
Open access |
12 Jan 2016 |
32 |
| 33 |
Role of ghrelin in regulating rabbit ovarian function and the response to LH and IGF-I
Alexander V. Sirotkin, J. Rafay, J. Kotwica et al. · Domestic Animal Endocrinology
|
23 Jan 2009 |
32 |
| 34 |
N‐terminally extended analogues of the K+channel toxin fromStichodactyla helianthusas potent and selective blockers of the voltage‐gated potassium channel Kv1.3
Shih‐Chung Chang, Redwan Huq, Sandeep Chhabra et al. · FEBS Journal
Open access |
9 Apr 2015 |
31 |
| 35 |
Buccal mucosal delivery of a potent peptide leads to therapeutically-relevant plasma concentrations for the treatment of autoimmune diseases
Liang Jin, Ben J. Boyd, Paul James White et al. · Journal of Controlled Release
|
4 Dec 2014 |
31 |
| 36 |
Structure, folding and stability of a minimal homologue from Anemonia sulcata of the sea anemone potassium channel blocker ShK
Bankala Krishnarjuna, Christopher A. MacRaild, Punnepalli Sunanda et al. · Peptides
Open access |
12 Oct 2017 |
30 |
| 37 |
Synthesis, folding, structure and activity of a predicted peptide from the sea anemone Oulactis sp. with an ShKT fold
Bankala Krishnarjuna, Jessica Villegas‐Moreno, Michela L. Mitchell et al. · Toxicon
Open access |
19 May 2018 |
29 |
| 38 |
Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis
Mark R. Tanner, Michael W. Pennington, Brayden H. Chamberlain et al. · Journal of Pharmacology and Experimental Therapeutics
Open access |
16 Feb 2018 |
28 |
| 39 |
The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways
Ejovwoke F. Dosunmu, Robert O. Emeh, Saurabh Dixit et al. · PLoS ONE
Open access |
3 May 2017 |
28 |
| 40 |
Immunogenicity and Long-Term Efficacy of Botulinum Toxin Type B in the Treatment of Cervical Dystonia
Robert B. Chinnapongse, Mark Lew, Joaquim José Ferreira et al. · Clinical Neuropharmacology
|
29 Aug 2012 |
28 |
| 41 |
Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin
Seow Theng Ong et al. · ACS Pharmacology & Translational Science
Open access |
14 May 2020 |
27 |
| 42 |
Food restriction, ghrelin, its antagonist and obestatin control expression of ghrelin and its receptor in chicken hypothalamus and ovary
Alexander V. Sirotkin, Silvia Pavlová, Manuel Tena‐Sempere et al. · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology
|
Aug 2012 |
27 |
| 43 |
Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
Ralf Bergmann, Manja Kubeil, Kristof Zarschler et al. · Scientific Reports
Open access |
12 Jun 2017 |
26 |
| 44 |
Some endocrine traits of transgenic rabbits. II. Changes in hormone secretion and response of isolated ovarian tissue to FSH and ghrelin
Alexander V. Sirotkin, Peter Chrenek, Krzysztof Darłak et al. · Physiological Research
Open access |
2008 |
26 |
| 45 |
Combinatorial libraries by portioning and mixing.
Árpád Furka, Bennett Wd · PubMed
|
Apr 1999 |
25 |
| 46 |
Identification, chemical synthesis, structure, and function of a new KV1 channel blocking peptide from Oulactis sp.
Punnepalli Sunanda, Bankala Krishnarjuna, Steve Peigneur et al. · Peptide Science
|
24 May 2018 |
24 |
| 47 |
Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of α V β 3 Integrin Activity
Jamila Hedhli, Andrzej A. Czerwiński, Matthew J. Schuelke et al. · Scientific Reports
Open access |
5 Jun 2017 |
24 |
| 48 |
KCa1.1 channels regulate β 1 ‐integrin function and cell adhesion in rheumatoid arthritis fibroblast‐like synoviocytes
Mark R. Tanner, Michael W. Pennington, Teresina Laragione et al. · The FASEB Journal
Open access |
20 Apr 2017 |
24 |
| 49 |
KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis
Mark R. Tanner, Michael W. Pennington, Satendra S. Chauhan et al. · Arthritis Research & Therapy
Open access |
7 Jan 2019 |
23 |
| 50 |
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria
Shih Chieh Chang, Charles A. Galea, Eleanor W. W. Leung et al. · Toxicon
Open access |
31 May 2012 |
22 |